急性髓性白血病的管理:一篇评论
Chetan Jeurkar1, Lana King2, David Baek2
1Sidney Kimmel Comprehensive Cancer Center, Department of Medical Oncology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA 19107, USA.
Cancers
|February 27, 2026
概括
针对性疗法,如menin,FLT3和IDH抑制剂,对急性髓性白血病 (AML) 亚组显示有前途. 然而,TP53突变的AML仍然需要更有效的治疗策略来改善存活率.
科学领域:
- 血液学恶性瘤是什么
- 基因组医学是基因组医学.
- 瘤学 治疗学 治疗学
背景情况:
- 急性髓性白血病 (AML) 呈现异质的结果,特别是在老年人和高风险患者.
- 基因组分析的进步刺激了向治疗,改变了传统化疗之外的治疗模式.
- 本综述重点介绍的是关于脑膜抑制,FLT3抑制,IDH抑制和TP53突变AML的新兴策略.
研究的目的:
- 审查目前的证据和急性髓性白血病 (AML) 的新兴治疗策略.
- 分析向疗法,包括menin,FLT3和IDH抑制剂,以及TP53突变AML的治疗方法.
- 根据临床和临床前数据,提供治疗进展的最新概述.
主要方法:
- 对已发表和正在进行的临床试验和临床前研究进行系统审查.
- 强调具有监管批准或重大临床开发的向药物.
- 分析机械学数据,反应率,生存结果和抵抗模式.
主要成果:
- 梅因抑制剂在NPM1突变和KMT2A重组的AML中表现出活性.
- FLT3 抑制剂提高了FLT3 突变AML的存活率,具有FLT3 野生型疾病的潜力.
- IDH抑制剂提高了疗效,但TP53突变的AML仍然具有挑战性,长期存活率较低.
结论:
- 针对性疗法在特定的AML分子子集中取得了先进的结果.
- 由于其预后不佳,TP53突变AML需要新的治疗策略.
- 生物标志物驱动的研究和组合疗法对于完善AML治疗和改善存活率至关重要.
更多相关视频
07:38Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
859
09:01Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
14.8K
相关概念视频
01:15Differentiation of Common Myeloid Progenitor Cells
4.1K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
4.1K
01:27Disorders of Leukocytes
2.1K
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
2.1K
01:22Bone Marrow Sampling and Transplants
1.8K
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
1.8K
01:22Myocarditis IV: Nursing Management
297
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
297